FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008...
WUHAN, China, June 24, 2019 /PRNewswire-AsiaNet/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) ...
Authors: LATEST ASIANET NEWS RELEASES